Paper41754792
Ferroptosis as a Novel Therapeutic Strategy to Overcome Multidrug Resistance in Colorectal Cancer.
Mahemuti D and 8 others. Pharmaceuticals (Basel), 2026. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Ferroptosis as a Novel Therapeutic Strategy to Overcome Multidrug Resistance in Colorectal Cancer. Papers, record 41754792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41754792
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ferroptosis as a Novel Therapeutic Strategy to Overcome Multidrug Resistance in Colorectal Cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2024D01C266 | Natural Science Foundation Project of Xinjiang Uygur Autonomous Region | PubMed | ||
| 32471260 | National Natural Science Foundation of China | PubMed |
Source PubMed
References224
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28445938 | Pirfenidone normalizes the tumor microenvironment to improve chemotherapy. | Oncotarget | 2017 | https://conductscience.org/library/papers/28445938 | PubMed |
| 2 | 33304242 | Ferroptosis, a Regulated Neuronal Cell Death Type After Intracerebral Hemorrhage. | Front Cell Neurosci | 2020 | https://conductscience.org/library/papers/33304242 | PubMed |
| 3 | 38259274 | Ferroptosis: a new antidepressant pharmacological mechanism. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/38259274 | PubMed |
| 4 | 29025909 | Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomas. | Haematologica | 2018 | https://conductscience.org/library/papers/29025909 | PubMed |
| 5 | 26686578 | Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein. | Biochem Pharmacol | 2016 | https://conductscience.org/library/papers/26686578 | PubMed |
| 6 | 12933815 | Role of XRCC1 in the coordination and stimulation of oxidative DNA damage repair initiated by the DNA glycosylase hOGG1. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12933815 | PubMed |
| 7 | 21081657 | A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer. | Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21081657 | PubMed |
| 8 | 37675227 | Overexpressed transferrin receptor implied poor prognosis and relapse in gastrointestinal stromal tumors. | Front Oncol | 2023 | https://conductscience.org/library/papers/37675227 | PubMed |
| 9 | 36313628 | The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. | Front Oncol | 2022 | https://conductscience.org/library/papers/36313628 | PubMed |
| 10 | 26251616 | Hypoxia-inducible factor-1α induces multidrug resistance protein in colon cancer. | Onco Targets Ther | 2015 | https://conductscience.org/library/papers/26251616 | PubMed |
| 11 | 35281878 | Comprehensive Analysis of Somatic Reversion Mutations in Homologous Recombination Repair (HRR) Genes in A Large Cohort of Chinese Pan-cancer Patients. | J Cancer | 2022 | https://conductscience.org/library/papers/35281878 | PubMed |
| 12 | 19403462 | Human ATP-binding cassette (ABC) transporter family. | Hum Genomics | 2009 | https://conductscience.org/library/papers/19403462 | PubMed |
| 13 | 29371429 | Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation. | Science | 2018 | https://conductscience.org/library/papers/29371429 | PubMed |
| 14 | 35912181 | Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer. | Front Oncol | 2022 | https://conductscience.org/library/papers/35912181 | PubMed |
| 15 | 34677685 | Systematic review and meta-analysis of tumour microsatellite-instability status as a predictor of response to fluorouracil-based adjuvant chemotherapy in colorectal cancer. | Int J Colorectal Dis | 2022 | https://conductscience.org/library/papers/34677685 | PubMed |
| 16 | 16373718 | Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP. | Mol Cancer Ther | 2005 | https://conductscience.org/library/papers/16373718 | PubMed |
| 17 | 32722234 | Overcoming Multidrug Resistance: Flavonoid and Terpenoid Nitrogen-Containing Derivatives as ABC Transporter Modulators. | Molecules | 2020 | https://conductscience.org/library/papers/32722234 | PubMed |
| 18 | 36338517 | A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options. | Explor Target Antitumor Ther | 2022 | https://conductscience.org/library/papers/36338517 | PubMed |
| 19 | 35990689 | Ferroptosis in sepsis: The mechanism, the role and the therapeutic potential. | Front Immunol | 2022 | https://conductscience.org/library/papers/35990689 | PubMed |
| 20 | 28499449 | PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy. | Mol Cancer | 2017 | https://conductscience.org/library/papers/28499449 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42796493 | Enhancing Anti-Cancer Efficacy in Colorectal Cancer Through Cannabinoid and Sodium Pentaborate Co-Therapy. | Molecules | 2026 | https://conductscience.org/library/papers/42796493 | PubMed |
| 42509799 | GPX4 in the Tumor Microenvironment: Not Just Inhibiting Ferroptosis, but Immuno-Metabolic Regulation. | Biomolecules | 2026 | https://conductscience.org/library/papers/42509799 | PubMed |
| 42422878 | RBMS3 promotes ferroptosis in colorectal cancer and is suppressed by M2 tumor-associated macrophages via STAT3 activation. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/42422878 | PubMed |
| 42353038 | Iron Metabolism in the Colorectal Tumor Microenvironment: From Preneoplastic Lesions to Cancer Progression. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353038 | PubMed |
Genes88
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41754792
GET https://conductscience.org/api/papers/v1/41754792/references?page=2